Cargando…
In Situ Metabolomics Expands the Spectrum of Renal Tumours Positive on (99m)Tc-sestamibi Single Photon Emission Computed Tomography/Computed Tomography Examination
BACKGROUND: Definite noninvasive characterisation of renal tumours positive on (99m)Tc-sestamibi single photon emission computed tomography/computed tomography (SPECT/CT) examination including renal oncocytomas (ROs), hybrid oncocytic chromophobe tumours (HOCTs), and chromophobe renal cell carcinoma...
Autores principales: | Papathomas, Thomas, Tzortzakakis, Antonios, Sun, Na, Erlmeier, Franziska, Feuchtinger, Annette, Trpkov, Kiril, Bazarova, Alina, Arvanitis, Alexandros, Wang, Wanzhong, Bozoky, Bela, Kokaraki, Georgia, Axelsson, Rimma, Walch, Axel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317898/ https://www.ncbi.nlm.nih.gov/pubmed/34337482 http://dx.doi.org/10.1016/j.euros.2020.11.001 |
Ejemplares similares
-
Machine Learning Integrating (99m)Tc Sestamibi SPECT/CT and Radiomics Data Achieves Optimal Characterization of Renal Oncocytic Tumors
por: Klontzas, Michail E., et al.
Publicado: (2023) -
Visual evaluation and differentiation of renal oncocytomas from renal cell carcinomas by means of (99m)Tc-sestamibi SPECT/CT
por: Tzortzakakis, Antonios, et al.
Publicado: (2017) -
Combining contrast-enhanced ultrasound, CT perfusion and (99m)Tc-Sestamibi SPECT/CT to guide diagnosis in a case of solid renal tumour
por: Kalarakis, Georgios, et al.
Publicado: (2020) -
Advantages of the (99m)Tc-sestamibi Single-Photon Emission Computed Tomography/Computed Tomography in Occult Parathyroid Adenoma and Concomitant Thyroid Papillary Carcinoma
por: Cadena-Piñeros, Enrique, et al.
Publicado: (2019) -
Comparison of Planar Imaging Using Dual-phase Tc-99m-sestamibi Scintigraphy and Single Photon Emission Computed Tomography/Computed Tomography in Hyperparathyroidism
por: Özçevik, Halim, et al.
Publicado: (2022)